IP Library Granted Patent US 10,080,847
Granted Patent B2
US 10,080,847 · App. 15/165,624 · Granted Sep 25, 2018

Safety device for a pre-filled syringe and an injection device

Inventors: Gareth Roberts (Cheshire, GB); John Slemmen (Mereyside, GB); Matthew Ekman (Cheshire, GB)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3202A61M5/326A61M5/3213A61M5/3245A61M5/3287A61M5/20A61M2005/2073A61M2005/3223A61M2005/3247A61M2005/3267A61M2205/583A61M2205/59
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,080,847
App. No.
15/165,624
Granted
Sep 25, 2018
Kind
B2
Abstract

According to the invention, a safety device for a pre-filled syringe with an injection needle comprises of a support body adapted to mount the pre-filled syringe, a needle shield slidably arranged with respect to the support body, a retention and locking means (M) for retaining and locking the needle shield with respect to the support body in a first and a second advanced position (PA 1 , PA 2 ) and in a retracted position (PR). The needle shield comprises an annular flange adapted to rest on the skin of the patient receiving an injection. The retention and locking means (M) are arranged at a distal end of the safety device.

Claims (30)

1. A safety device for a pre-filled syringe with an injection needle, the safety device comprising:

a support body adapted to receive the pre-filled syringe;

a needle shield slidably arranged with respect to the support body;

a retention and locking mechanism (M) configured to releasably retain the needle shield with respect to the support body in a first advanced position (PA 1 ) and lock the needle shield with respect to the support body in a second advanced position (PA 2 );

wherein the retention and locking mechanism (M) is generally arranged distally within the safety device, and

wherein the needle shield in the first advanced position (PA 1 ) protrudes from the support body in a distal direction by a first distance (D 1 ) and the needle shield in the second advanced position (PA 2 ) protrudes from the support body in the distal direction by a second distance (D 2 ), wherein the first distance (D 1 ) is smaller than the second distance (D 2 ).

2. The safety device according to claim 1 , wherein the retention and locking mechanism (M) is configured to release the needle shield from the first advanced position (PA 1 ) by a linear movement of the needle shield with respect to the support body.

3. The safety device according to claim 1 , wherein the retention and locking mechanism (M) comprise at least one deflectable resilient arm.

4. The safety device according to claim 3 , wherein the at least one deflectable resilient arm is arranged with the needle shield as one piece.

5. The safety device according to claim 3 , wherein the at least one deflectable resilient arm latches to a recess formed in a distal region of the support body.

6. The safety device according to claim 5 , wherein the at least one deflectable resilient arm latches to the recess to retain the needle shield in the second advanced position (PA 2 ).

7. The safety device according to claim 5 , wherein the at least one deflectable resilient arm is deflected in a radial inward direction and subsequently unbends when latching to the recess.

8. The safety device according to claim 3 , wherein the at least one deflectable resilient arm comprises two inwardly deflectable resilient arms that are arranged opposite to each other.

9. The safety device according to claim 1 , wherein the needle shield is biased with respect to the support body in the distal direction by a spring.

10. The safety device according to claim 9 , wherein the spring comprises a distal end which bears against a collar arranged on the needle shield.

11. The safety device according to claim 9 , wherein the spring comprises a proximal end which bears against the support body.

12. The safety device according to claim 1 , wherein the retention and locking mechanism (M) and the needle shield are configured to interact with each other at a distal end of the safety device.

13. The safety device according to claim 12 , wherein the retention and locking mechanism (M) comprises a recess arranged at the distal end of the safety device, the recess configured to releasably retain the needle shield at the distal end of the safety device.

14. The safety device according to claim 1 , wherein a portion of the needle shield is supported within the support body.

15. The safety device according to claim 14 , wherein the portion of the needle shield supported within the support body comprises at least one deflectable resilient arm.

16. An injection device comprising:

a pre-filled syringe; and

a safety device comprising:

a support body adapted to mount the pre-filled syringe;

a needle shield slidably arranged with respect to the support body;

a retention and locking mechanism (M) configured to retain and lock the needle shield with respect to the support body in a first advanced position (PA 1 ) and a second advanced position (PA 2 );

wherein the needle shield comprises an annular flange adapted to rest on an injection site,

wherein the retention and locking mechanism (M) are arranged at a distal end of the safety device, and

wherein the needle shield is movable from the first advanced position (PA 1 ) to a retracted position (PR) and further to the second advanced position (PA 2 ), wherein the needle shield in the first advanced position (PAT) protrudes the support body in a distal direction by a first distance (D 1 ) and the needle shield in the second advanced position (PA 2 ) protrudes the support body in the distal direction by a second distance (D 2 ), wherein the first distance (D 1 ) is smaller than the second distance (D 2 ).

17. The injection device of claim 16 , wherein the pre-filled syringe contains a drug containing at least one pharmaceutically active compound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2016
From: ROBERTS, GARETH; SLEMMEN, JOHN; EKMAN, MATTHEW
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 039540/0530 →
Priority Claims (1)
EP 11150080 · Jan 4, 2011 · regional
Continuity (2)
Continuation 13997370
Related Publication 20160271339A1 · Sep 22, 2016
Cited By (6)
US 12,453,822 US 12,491,323 US 12,551,633 US 12,558,495 US 12,569,625 US 12,691,228